> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Nymalize Not Withdrawn Due to Safety/Efficacy: FDA
- URL: https://www.fdaweb.com/nymalize-not-withdrawn-due-to-safety-efficacy-fda/
- Published: 2021-02-17T12:00:00.000Z
- Updated: 2026-09-14T16:47:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148678

*Federal Register* notice: FDA has determined that Arbor Pharmaceuticals’ Nymalize (nimodipine) oral solution was not withdrawn from sale due to safety or effectiveness reasons. The determination will allow FDA to approve ANDAs for this reference product if all other legal and regulatory requirements are met. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-02-17/pdf/2021-03083.pdf?ref=fdaweb.com).